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Abstract
Background: This paper examines how family and social relations facilitate and inhibit adherence to
antiretroviraltherapy (ART) for people living with HIV (PLH) who have underlying substance use disorders and are
transitioningto the community post-incarceration.
Methods: Combining the methods of inductive close reading and constantcomparison, we analyzed the data from
30 semi-structured interviews of PLH who had recently transitioned to thecommunity within the previous 90 days.
Results: Three central themes were anticipated as important socialrelationships post-release: self-reported family,
friends and clinicians. Among these, four sub-themes (social isolation, ‘double jeopardy’, search for belonging, and trust
and respect) emerged, highlighting how they impacted ART adherence. Post-release, participants returned to resource-
poor communities where they experienced socialisolation. ART adherence was enabled by having a purpose in life,
which correlated with having robust family support structures. Many former prisoners felt that a chasm between them
and their families existed, both because of HIV stigma and their addiction problems. In this context, relationships with
untrustworthy friends from their druguse networks led to relapse of drug use and risky behaviors, jeopardizing
participants’ ART adherence and persistence. To avoid the double jeopardy, defined as seeking friends for support but
who were also the ones who contributed to drug relapse, participants searched for new social anchors, which often
included their healthcare providers who represented trusted and respected persons in their life.
Conclusions: While some former prisonersperceived doctors as uncaring and their relationships asymmetrical, positive
relationships with these providers,when respect and trust was mutual, reinforced the participants’ sense of belonging
to what they called ‘the world that don’t do drugs’ and motivated them to adhere to ART.
Keywords: People living with HIV, Addiction, Prisoners, Adherence, Antiretroviral therapy, Social relationships, Family,
Friends, Clinicians, Qualitative interviews, Trust in Physician
Background
Antiretroviral therapy (ART) adherence (i.e., taking medica-
tions as prescribed) and persistence (i.e., remaining on
medications continuously) (Bae et al. 2011) is crucial to so-
ciety and people living with HIV (PLH) who transition
through prisons and jails. Consequently, ART adherence
and persistence remains necessary for ‘Treatment as Pre-
vention’ to work. With 2.2 million people incarcerated in
the U.S. and 12 million transitioning through these facilities
annually, criminal justice involvement disrupts the lives of
as many as 1 in 6 PLH (Spaulding et al. 2009). It is well-
documented that most PLH in prisons or jails initiate ART
while incarcerated and have high levels of ART adherence
and viral suppression while there (Meyer, Cepeda, Springer,
et al. 2014; Springer et al. 2004; Substance Abuse and Men-
tal Health Services Administration (SAMHSA) 2009).
These benefits, however, are often not sustained for nearly
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three-fourths of those prescribed ART, as they either be-
come suboptimally adherent with their medications or dis-
continue them completely within 3 months post-release
(Meyer et al. 2014; Springer et al. 2004). Now that guide-
lines recommend ART for all PLH, regardless of CD4 cell
count, new and invigorated efforts are essential to under-
stand the transitional process for PLH who re-enter the
community after incarceration.
Numerous factors impede ART adherence in former
prisoners with substance use disorders (SUDs). These in-
clude organizational and bureaucratic barriers to care
(Holtzman et al. 2015), reintegration activities as com-
peting demands to accessing care (Sidibe et al. 2015a),
poverty and economic insecurity (Harding et al. 2014),
lack of health insurance and secure housing (Chen et al.
2013; Zelenev et al. 2013), lack of addiction treatment
services and challenges with coordinating treatment for
multiple comorbidities like mental illness, HCV and
other chronic medical conditions, especially as PLH age
(Althoff et al. 2013; Springer et al. 2011), and relapse to
drug use (Binswanger et al. 2011). In New Haven, factors
impeding connection of former prisoners to HIV care
are exacerbated by the context of New Haven being the
7th poorest city for its size and high socio-economic dis-
parities with one third of inhabitants living below the
2011 Federal poverty level (compared to 9 % statewide).
Experiences of post-incarceration transitions for former
prisoners in New Haven are also shaped by higher racial
disparities in incarceration rates between black and white
residents in CT than nationwide (Copollo and McCarthy
2008) and harsher mandatory minimum prison-term pen-
alties for non-violent drug offences (De Avila 2015).
Central to improving ART adherence in this vulnerable
population is reducing relapse to drug and alcohol use
(Kamarulzaman and Altice 2015). Social support from
family, friends, and community enables retention in care
(Holtzman et al. 2015), reduces risk of relapse, and
alongside high interpersonal trust and civic participation,
forms social capital (Berkman 2000) which is a major de-
terminant of health (Kawachi et al. 2004). Research
within prison settings suggest that trust positively influ-
ences ART acceptance and adherence (Altice et al. 2001;
Mostashari et al. 1998), and healthcare utilization among
people who inject drugs (PWID) (Ostertag et al, 2006).
The term ‘trust in respected others’ was offered to more
broadly include elements of trust beyond the physician
(Hammett et al. 2015b; Ostertag et al. 2006; Sidibe et al.
2015b), including bi-directional relationships (such as
with the healthcare provider) that promotes better
health outcomes. HIV-infected criminal justice popula-
tions, however, may have little contact with family and/
or have non-supportive family relationships, and thus
lack these sources of social support (Meyer et al. 2013).
They may search for respected and trustworthy
connections with healthcare linkage specialists (either
peers or professionals) who have been shown to promote
patient motivation to better engage in care (Broaddus et
al. 2015). Peer relationships may conversely place PLH
in jeopardy if peers endorse risk behaviors: social net-
work research suggests spreading of such behaviors
through social contagion (Christakis and Fowler 2013).
As PLH are often socially isolated and have fewer oppor-
tunities than other individuals (Phillips 2011), it is cru-
cial to examine when and how social relationships may
alternatively serve as potential barriers or facilitators to
ART adherence and retention in care. In line with the
goal of developing social environments that bolster
formerly incarcerated individuals’ ability to manage liv-
ing with HIV (Auerbach 2009), this paper examines,
using a qualitative lens, how social and family relation-
ships influence ART adherence among PLH who re-
cently transitioned from prison to the community.
Qualitative inquiries add contextual understanding to
extant quantitative literature about post-release transi-
tion from correctional facilities to the community (Iroh
et al. 2015; Morozova et al. 2013; Springer et al. 2011),
specifically knowledge about the lived reality of these
persons’ experiences with family, friends and healthcare
providers (Hammett et al. 2015b; Sidibe et al. 2015b),
and examines exactly how and why they experience real-
life exigencies with adhering to ART after release from
prison. How to optimize ART adherence and persistence
is crucial for incarcerated PLH already engaged in care
to achieve optimal results from the individual and public
health perspectives. Revealing relationship-connected
factors that shape adherence among those already in
care is also important to provide new insights on issues




We used data from 30 qualitative interviews with PLH
who were released from prison or jail within the previ-
ous three months. A convenience sample of participants
was recruited from two large quantitative studies that
examined health behaviors and linkage to care among
PLH who were transitioning to care in New Haven, Con-
necticut (Bhushan et al. 2015). One purpose of the in-
depth qualitative interviews was to understand what
could serve as barriers and as facilitators for taking ART
in the context of transition from prison to community.
The interview guide included open-ended questions
based on extant literature and was developed to under-
stand better how transition shaped social recovery, spe-
cifically re-engaging of ex-prisoners with the community
and with the social roles they find meaningful (Pelletier
et al. 2015), and ART use for recently released PLH.
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One of the open-ended questions involved how they
were managing their ART currently and if they described
taking it every day as prescribed, this was recorded as
being adherent; objective measures were not used to de-
fine adherence. All interviews were conducted in late
2011 in private settings by one of the authors (AB) and
lasted 45 – 90 minutes; only one participant was re-
incarcerated and was interviewed in jail. Interviews were
audio-recorded and transcribed verbatim. The study was
approved by Yale’s Institutional Review Board.
Study population
Eligibility criteria for participation included only PLH
who had been released from prison or jail in the previ-
ous 3 months. All participants, consistent with the HIV
epidemic in criminal justice populations in Connecticut,
had underlying SUDs, mostly with related risk for HIV
being past or current drug injection (Meyer et al. 2014;
Meyer et al. 2014). Participants were thus documented
as being HIV-infected with an underlying substance use
disorder (i.e. participants self-reported having used
drugs in the past and/or trying to stay clean), and were
returning to communities in Connecticut, many of
which had high rates of concentrated poverty with up to
48 % of the population living below the poverty line
(Buchanan and Abraham 2015). All participants were
linked to Ryan White-subsidized HIV care and ART
through the parent studies, were aware of having HIV,
and had been prescribed ART during their most recent
incarceration.
Analysis
Following the principles of narrative analysis of text
(Denzin and Lincoln 2008), interview transcripts were
first closely and repeatedly read to familiarize authors
with participants’ experiences with community transi-
tion, ART adherence, and social relationships. We used
the ‘comment box’ function in Word to highlight cogent
quotes. One co-author (JR) coded the interview tran-
scripts using NVivo9 qualitative data management soft-
ware (QSR International Pty Ltd. Version 9, 2010). The
coding structure was initially developed by two co-
authors (AB and JR) to include both anticipated and
emergent themes and reviewed and refined by all co-
authors to ensure agreement. This paper is based on the
detailed analysis of how family and social relationships
shape ex-prisoners’ adherence to ART. We took a quali-
tative interpretive approach, combining the methods of
inductive close reading and constant comparison (Green
and Thorogood 2004; Gubrium and Holstein 2009) to
examine subthemes that concerned the role of social
and family relationships on ART adherence . Each tran-
script was read line by line by the coder (JR) to identify
sub-themes. Bi-weekly discussions among all co-authors
served to review the coding as it progressed and ensure
inter-rater reliability through discussion of any disagree-
ment. During these meetings we identified and analyzed
in more detail four emergent sub-themes that
highlighted both positive and negative perceptions of so-
cial relationships and their impact: (1) social isolation;
(2) trust and respect; (3) double jeopardy of relation-
ships; and (4) search for social anchors and belonging.
These sub-themes were present across all identified rela-
tionships that helped facilitate or impede ART adher-
ence, namely: participants’ relationships with family,
friends, and clinicians. While the interviews asked about
family, friends, and clinicians, the questions did not im-
pose a definition. Consequently, participants were
allowed to define who was considered as family, friends,
or clinicians. For example, some participants described
clinicians whom they greatly appreciated as being almost
like family. Conversely, others stated that indifferent par-
ents or siblings ceased being their family while others
explained their family included only their spouse and
children. Similar nuances emerged with how some par-
ticipants defined ‘friends’. Below we discuss the results
of our analyses, presenting how the three kinds of partic-
ipants’ relationships facilitated or hindered ART
adherence during transition from jail/prison to the
community.
Results
Participants’ (N = 30) characteristics are described in
Table 1 with the majority being marginally housed, few
were married, and only one was employed.
ART adherence was supported by a sense of belonging
and having a purpose in life, which sometimes stemmed
from having robust family support structures. Partici-
pants who had close positive relationships with family
wished to stay well and alive for the sake of loved ones,
which promoted ART adherence. Many ex-prisoners,
however, felt that they had permanently severed any
meaningful relationships with their families because of
their addiction problems and discrimination from HIV.
In this context, social relationships with friends from
their drug-use networks made participants more vulner-
able to relapse to risky behaviors, leading to non-
adherence and non-persistence of ART use. To escape
this jeopardy, participants searched for other social an-
chors. Often, their closest social relationships were with
their HIV care providers. While some ex-prisoners per-
ceived doctors as uncaring and patriarchal, positive per-
ceptions of relationships with these providers reinforced
the participants’ trust and sense of belonging to what
they called ‘the world that don’t do drugs’ and motivated
them to adhere to ART. Below we present these find-
ings, illustrating them with the participants’ quotes.
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Family: support facilitates but ostracism hinders ART
adherence
Participants in our study varied in terms of their family
backgrounds and the nature of their relationship with
their family. Some participants took pride in growing up
in stable households that Anderson (1999) described by
the folk term ‘decent’ that had no involvement with the
criminal justice system, saying:
None of my family has been in trouble AT ALL.
I grew up in a good family. And I’d never been in
trouble with the law.
Such households were often headed by a respected fe-
male figure like a mother or a grandmother. This is illus-
trated in the following anecdote where the death of this
figure disrupted a family’s ties and togetherness:
We all used to be so close. And my grandmother dies
and everything gets out of whack and falls apart. She
was the whole to our family for everything.
Participants who came from intact families stressed
the importance of love and support from their family in
ensuring a smooth post-prison transition:
I didn’t really have no problem transitioning [from
prison to the community] ‘cause I got [a] pretty big
family. If I ask them, they’ll help me. I got people that
love me.
Families also anchored participants in the present and
gave them a sense of purpose for the future and a goal
to live for, which motivated them to adhere to ART:
For the last 20 years, I’ve been okay ’cause I take care
of myself. I know I need this [ART medication] and I
have a family. I don’t want to die. So I do take care.
I can overcome [HIV], the drugs, because I got a lot of
people that loves me. I got my family supporting me. I
got my wife supporting me. I got my kids supporting me.
Everybody is counting on me. So all eyes are on me.
My wife, she make sure I go to doctor’s appointments.
But family ties were not supportive of all participants.
Family members often struggled with the same issues as the
participants themselves, and had few resources or agency to
provide support to others. In fact, many participants spoke
about family dysfunction and the poverty, violence or drug
use they witnessed or experienced from a young age:
I grew up in a housing project. So, at nine years old, I
tried marijuana and I liked it.
I have a sister that passed away. Her boyfriend was
an intravenous drug user. And he died of AIDS, and
she did too.
When their family members either died or themselves
struggled with crippling substance use disorders or other
co-morbid conditions, these participants could not
count on them for emotional or instrumental support to
keep their appointments and adhere to their ART. As all
our participants had a history of substance use disorders,
they frequently noted how their family ostracized them:
I have a sister here in this town. I see her passing and
we’ll have a five-minute conversation. But I'm not allowed
to go to her house. I don’t know her phone number.
Another participant shared that
Drugs ruined my life. My friends and family lost
respect for me.
And yet another one stated that
They're [his parents] somewhere either in Alabama or
Florida. I haven't seen them in over 20 years. Twenty
Table 1 Participants' characteristics
Participants’ characteristics N




Sex Male 25 (83 %)
Female 5 (17 %)
Race Black 17 (57 %)
Hispanic 10 (33 %)
White 3 (10 %)
Housing situation Halfway house/transitional
HIV housing shelter
11 (37 %)
Homeless 8 (27 %)
Living with friends or family 6 (20 %)
Own or rent house/apartment 4 (13 %)
Re-incarcerated 1 (3 %)
Source of livelihood Employment 1 (3 %)
Social security 25 (83 %)
None 4 (13 %)
Marital status Married 3 (10 %)
Single 14 (47 %)
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years ago, I needed help. “Don’t call here.” And their
phone number was changed.
While drug addiction may have started participants’
alienation from family, receiving their HIV diagnosis
deepened this divide and made family support more
tenuous. Participants often self-isolated, out of internal-
ized HIV stigma and fear and shame reinforced by the
process of receiving care:
You have to go there every day and you have to get
blood tests every time. And that’s not normal. It made
me stay away from my family. Because I am HIV+
and they’re not, I just push myself away. I still call my
dad, talk to him, but I haven't seen them in years.
In sum, family support could be a powerful motivator
for ART adherence for those who had intact and robust
family networks. Many individuals, however, lacked
family support either due to membership in families that
had chronic medical illnesses or substance use disorders
and therefore were ill-equipped to provide material and
psychological support. This, in turn, led to self-isolation
or ostracization from their families due to their own
criminal, drug use or HIV histories.
Friends: support by respected friends enabled recovery
while interactions with drug-using friends facilitated
drug-use relapse
Individuals who had poor family support relied to a greater
degree on their friendships. When relationships with
friends were functional (i.e., supportive), this gave partici-
pants emotional support to overcome addictions and in-
strumental support with post-incarceration transition. As
participants noted, this helped reduce their risk behaviors,
avoided relapse to drug-use, and stabilized their life:
A cellie - a friend of mine that’s my best friend – she
said, “Start reading the Bible.”And ever since I read it
every day. I truly believe reading the Bible helped me
to stay clean.
I didn’t have a place to stay, when I was in the
halfway house. So, I have a friend that’s HIV positive.
He is a gay guy, and he's a very, very good friend of
mine. And he told me about resources he knew about.
Longer-term friendships were also valued and while
not directly instrumental to health-seeking, gave partici-
pants a sense of continuity and social belonging:
All my friends that I grew up with and played football
or baseball, or basketball with, once a year we have a
reunion, and that’s when I see everyone.
Not all participants had trustworthy friends willing to
help them along their transitional journey. Additionally,
even these valued friends had similar vulnerabilities as
the study participants regarding health problems and
criminal justice involvement. Participants longed to have
reliable friends who would care about them and could
provide support. Instead, many participants experienced
social isolation, noting that friends did not write or visit
them while they were incarcerated, and ignored them
after release:
[I was in jail] two and a half years. So nobody wrote me.
What I can consider a friend, I wouldn’t be staying in the
shelter, right now. “Come on, [name]. Come stay on my
couch ‘til you get on your feet.” Or, “I ain’t got no room ,
but you can make your pallet over there.” “You ain’t gotta
be in the street.” No, I don’t have any good friends.
There was also a broader sense of social
marginalization that individuals experienced beyond
their individual friendships. In the same way that many
individuals noted being alienated from their families,
participants felt excluded from their social communities
due to stigma related to HIV:
When I first found out that I had it, they used to whis-
per: “She is HIV. Don’t touch her.”
From the vantage point of their experiences of illegal
activities, addiction, and involvement with the criminal
justice system, participants said that:
There are two worlds. The world that do drugs and
the world that don’t do drugs.
Participants saw themselves living in a different world
from people who did not use drugs, from which they felt
excluded and disengaged. They furthermore felt unworthy
of the company of individuals from this perceived alter-
nate world, a notion that affected their self-esteem and
feeling of acceptance. As these participants stated,
I’ll never be somebody…I’ll never be good.
All the people that doing good, have a job, eating,
drinking a beer a week. You can't find those people to
socialize with because they don’t want to socialize with
you ’cause they are thinking different, better, and they
will not go down to that level.
While feeling ignored or self-excluded from ‘the world
that don’t do drugs’, soon after release participants en-
countered multiple opportunities to reconnect to ‘the
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world that do drugs’—the world from which many ori-
ginally felt they hailed—which was a pathway to drug re-
lapse and non-adherence to ART. Participants shared that
upon release, their ‘street friends’ easily offered them drug
credit, suggesting they could pay them back later. Given the
chronic and recurring nature of addiction, such offers were
hard to resist, and given the participants’ social isolation and
other unmet needs like housing and employment, many re-
ported getting re-involved with friends from ‘the world that
do drugs’, despite recognizing that these relationships were
toxic and harmful to their goals of addressing their sub-
stance use disorders, managing their HIV, and avoiding re-
incarceration. In contrast to true and respected friends, par-
ticipants called these friends in risky behaviors ‘associates’:
The only friends I have are my friends when I buy drugs
or drink. So is that a friend? No, that’s an associate.
A friend of mine charges me $50 a week [for room]. It's
in the heart of crack city. [It helps trigger] there’s no
doubt. It's all around me. It's in my living room.
If I get with the wrong crowd, for days I’d be up running,
ripping, hanging out. So I watch who my friends is now
because they don’t care. As long as you spending money,
they gonna party with you. They ain’t gonna say, “Oh,
yo, yo, check yourself, stop for a minute. Yo, I like you a
lot as a good friend. You need to take your meds”.
Clinicians: positive symmetrical relationships promoted
ART adherence but dismissiveness undermined trust
Oftentimes, participants reported experiences of feeling
uncared for, ignored, and just not taken seriously by
some clinicians they had encountered. They were frus-
trated by asymmetrical relationships where they as pa-
tients felt excluded from decisions and ‘acted upon’ by
their providers. Encounters with dismissive medical staff
reinforced participants’ suspicion and mistrust in clini-
cians, whom they regarded as heralds of bad news. Par-
ticipants resented when their questions to health-care
providers went unanswered and their reaction was to
withdraw, or even avoid these professionals altogether:
They took my blood. I want to know why they took the
blood. I asked them. They gave me some little skinny
piece of paper that said they took this, this, this, this,
and this. And then they circled this thing, and nobody
tells me what the circle’s for. I got half answers.
I don’t like doctors period. This is my first time dealing
with anything in a white coat. I don’t want to hear
what he have to say. ‘Cause I already have too much
to carry for me to hear another bad news.
Not all clinicians, however, were painted with this
same brushstroke. Participants distinguished between
‘caring’ and ‘uncaring’ clinicians, both within the prison
medical system and in the community:
There’s some staff that honestly care about the well-
being of a person. And there some that just don’t care.
“You're just here to be warehoused. Get out of my way.
I'm just here to do my eight hours”.
Some doctors, I think, try to talk to you, include you in
to whatever they’re trying to show you to help you live
longer. Some doctors not. They just want you in and out.
Oftentimes, a positive encounter with a ‘caring’ clin-
ician who treated the patient with respect happened in
the context of incarceration, was associated with HIV
diagnosis and treatment, and turned into a long-
standing relationship. In the context of such symmetrical
relationships, participants trusted their doctors, felt posi-
tively about shared-decision making and ownership, and
felt accepted and safe to be honest about their vulner-
abilities, including their high risk behaviors, all of which
were ultimately important for their adherence to ART:
[My] doctor very clearly explains things that he’s doing
to [me]. We have a good relationship. They sent him to
me almost eight years now, and we just clicked. He likes
me. I like him. I'm honest. I don’t play games. If I'm
doing something, I’ll tell him. I'm not gonna lie to him.
A key element in positive symmetrical patient-doctor re-
lationships was that by including patients in treatment de-
cisions, doctors created safe spaces of mutual trust where
patients felt empowered to engage with information about
their illness and make decisions about their healthcare:
I try to participate in my treatment. Stay educated,
ask questions. I been reading [on HIV] for years. I feel
comfortable with them [the nurse and the doctor].
Health then became a teamwork goal, as in this situ-
ation, where a participant spoke with pride of the valid-
ation she received from her doctor for showing steady
continuous progress towards recovery:
And [the doctor] told me I was the most-improved
HIV patient he’s ever worked with. Like, he’s never seen
their health bounce back so fast. And I'm very excited
about that.
Certainly, relationships with clinicians included a de-
gree of performance and what Anderson (1999) called
‘gloss’, which facilitated smooth social interactions at the
level of small talk pleasantries, and participants were
realistic about it:
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I'm a people person. I got along with them doctors.
Also participants described how doctors occasionally
put pressure on patients regarding their drug use and
made prescription of ART conditional on their non-
relapse. This obvious display of the doctors’ power could
cause anger, a sense of humiliation, and abandoning
treatment, unless the patient respected the doctor un-
equivocally and trusted the doctor was acting in his best
interests:
I got this doctor for 10 years. He was my doctor in jail,
in ’96. And he told me, “If you’re going back to the
community and you’re doing drugs, I don’t give you no
medication.” Well, [I changed] for him ’cause he is a
good doctor, you know what I mean?
Participants who, as described earlier, perceived they
had a deficit of credibility and often lacked supportive
relationships with family and friends, cherished positive
relationships with doctors, which gave a sense of belong-
ing and bridging to ‘the world that don’t do drugs’, enab-
ling participants’ motivation to live, giving them hope,
and making adherence to ART meaningful:
Because I want to live, I know I have to take the
medication. It's simple.
I'm starting to take it [ART] more serious ‘cause I want
to live a little longer anyway.
Managing my HIV is, basically, just taking your meds,
doing what your doctor tells you to. And I do that
faithfully. I don’t miss a day. Never miss a day.
Indeed, in describing relationships with caring doctors,
participants invoked the concepts of family and friends,
meaning that they were treated by doctors as their own
kin, and signifying that participants felt accepted, sup-
ported and cared for on a profoundly human level:
I like going to see Dr. X, I look at him not just a
doctor, as a friend.
I have my adoptive mother, Dr. Y, she's the chief
psychiatrist of [hospital]. When I was in jail, she sent
$50 every month. And she’s been like a mother to me.
Even to this day, once a month she comes up here, and
visits me. She's just been very supportive of me.
Even supportive symmetrical relationships with clini-
cians had to endure strain. With substance use disorders
being chronic, relapsing conditions and the risks of drug
exposure in impoverished communities, participants al-
ways ran the risk of drug relapse and medication non-
adherence, despite the stern warnings from their trusted
physicians. In the words of this participant,
There’s a word that a lot of us use out in the street. It’s
‘I don’t give a fuck’. It’s something that we use when
we’re on this mindset that we just don’t care. A lot of
times, I really didn’t care. All I wanted to do was get
high and just run the streets, and that’s what I did.
Yet many of our participants had longstanding HIV in-
fection, and their references to having the same HIV
doctor for many years suggested that relationships of
mutual trust and respect with clinicians tended to be ro-
bust and unconditional.
Poverty and lack of social capital undermine participants’
engagement in care
Enabling as they were to ART adherence, positive rela-
tionships with trusted doctors were nonetheless estab-
lished within the context of individuals’ experience of
the impoverished and resource-poor communities to
which they returned, as this participant so cogently
summarized:
But you can't be healthy unless you have all of this. I
can't be healthy if I don’t have a place to stay. And I
can't be healthy if I'm not eating right. I can't be
healthy if I don’t have a job. And I can't be healthy if I
don’t have clothes. You got my vicious circle?
In many participants’ estimations, the ‘world that don’t
do drugs’ was where all the medical and economic re-
sources were located, and the participants had to ven-
ture there as a condition of their existence. In that
process, they felt they encountered discrimination,
prejudice, and hostility (whether or not it was ‘object-
ively’ true) from the criminal justice authorities and
other social service agencies and entitlement programs
whose task it was to allegedly help them post-
incarceration, which contributed to anger, resentfulness,
and suspicion. An example of final resignation is shown
in the following quote from a participant who perceived
obtaining a job post-incarceration as an unattainable
dream:
Nobody’s hiring right now. I wouldn’t care if it was
mopping, sweeping the floor right now. NOTHING. If I
had a job right now, it would be beautiful. But it's not
in the making right now. God didn’t put it in my path,
yet.
Despite this disabling context of poverty and social in-
equality, clinicians played an important role in enhan-
cing the participants’ perception of their social capital,
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meaning the inclinations to do things for each other that
arise from the collective values of social support
(Berkman 2000). As a result, participants expressed a
sense of belonging to society from which they had
previously felt alienated, and voiced how they wanted
to help other people in their communities:
I'm an addict. I know that if I use, I'm gonna die and I
don’t want to die today. I want to be a good mother, a
good grandmother. I want to be all I can be. I want to
be a drug counselor and I'm gonna do it and I know
I'm gonna be good at it, too, because I've been through
everything. I've been through the virus. I've been an ex-
gang member. I been incarcerated. I been on crack,
heroin. I've done it all and I think those people make
the best counselors. And I want to work with kids.
Civic engagement is one of the key elements of social
capital (Berkman 2000). Thus the participants’ enthusi-
asm to put their experiences with addictions, HIV, and
criminality to public use through engagement in risk
prevention programs may indicate that social capital
goes hand in hand with ART adherence, mutually bol-
stering one another:
I just love doing things to be a part of stuff. If
somebody might write about me, one day, I want to be
one of the faces of HIV and AIDS.
While ‘trust in respected others’ (Altice et al. 2001)
and a sense of social belonging stemming from the par-
ticipants’ positive relationships with their HIV care pro-
viders were perceptual categories, they had real and
practical consequences for participants, reaffirming their
willingness to live by adhering to their appointments
and prescribed ART regimens:
I got this thing: if I go to all my appointments, it’ll give
me a reason to live.
Discussion
Strategies that effectively improve access to HIV services
and adherence to ART are especially crucial for improving
health outcomes for HIV-infected PWIDs (Altice et al,
2010), especially those who transition from prisons and jails
to communities (Springer et al, 2011). We found that partic-
ipants’ relationships with family, friends, and clinicians
could either facilitate or jeopardize their ART adherence. In
all three instances, with family, friends, and clinicians, posi-
tive and symmetrical relationships that were based on trust
and mutual respect promoted the participants’ sense of so-
cial belonging and ability to persevere with ART. Conversely
social isolation and ostracism made participants more vul-
nerable to drug relapse and discontinuing ART. This study
contributed to the existing literature (Althoff et al. 2013;
Bae et al. 2011) by disentangling how social relationships in-
fluence ARTadherence. Though others have described indi-
vidual and healthcare contributors to engaging in HIV
generally (Hammett et al. 2015b; Sidibe et al. 2015b; Swan
2015), this study focused on ARTadherence and persistence
and focused specifically on how supportive and positive so-
cial relationships based on mutual respect and trust, includ-
ing relationships with clinicians in the absence of other
kinds of social support, can alleviate feeling alienated from
others, which was commonly described by this group of so-
cially marginalized PLH who had transitioned from prison
or jail to the community where they lived. This support
from ‘trusted others’ provided former prisoners hope, a
sense of purpose and social belonging, which are crucial
for motivating them to adhere to ART.
Concerning the role of family, our findings echo a recent
qualitative study of community-based health care and ser-
vice professionals that observed that HIV-infected former
prisoners often have to work very hard to rebuild relation-
ships with their families upon release, placing HIV care at
a markedly lower priority (Sidibe et al., Sidibe et al. 2015a).
Positive relationships with family could bolster health-
seeking by giving participants a sense of purpose and be-
longing as well as instrumental support to adhere to ART
(Friedman et al. 2007). Yet participants’ family members
often either struggled with the same vulnerabilities as the
participants themselves, or ostracized participants for fear
of recurring economic and social risks stemming from re-
current substance use, and compounded by the combined
stigma of HIV, drug-use, and prison experiences, which
has been described in research from other countries
(Rudolph et al. 2012) and the US related to overlapping
stigmas in African American men (Brinkley-Rubinstein
2015). Evidence from outside the US suggests that in the
context of prejudice and myths, ostracism of HIV-infected
drug-using members is a way of managing secondary HIV-
and drug-related stigma directed at families (Salter et al.
2010), and we observed a similar process here.
Concerning relationships with friends, we found that
participants who saw themselves interacting with ‘the
world that do drugs’ felt alienated from what they called
‘the world that don’t do drugs’ and perceived mutually
respectful friendships bridging the two worlds as un-
likely. Instead, recently released PLH who shared com-
mon vulnerabilities and experiences became important
sources of emotional and instrumental support for each
other in managing their HIV and substance use disor-
ders, connected in their close relationships by common
experiences and goals. This echoes earlier research that
friends and peers can exert positive influences on
released prisoners, especially if those influences are
harnessed through a health-promoting lens (Broadhead
et al., 2002). Relationships with friends, however, may be
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dangerous when they facilitate relapse to drug use. Back
in their resource-poor communities where the drug
economy flourished due to poverty and unemployment
(Anderson, 2011), we found that participants encoun-
tered many untrustworthy former friends they called as-
sociates, who reintroduced participants to drug use
networks. Close physical proximity to such networks,
their omnipresence in resource-poor communities, and
multiple connections between participants and network
members through shared housing and other scarce re-
sources constituted a ‘risk environment’ (Rhodes et al.
1999) and invoked the social contagion of risky behav-
iors (Christakis and Fowler 2013), leading to relapse, re-
incarceration, and non-adherence to ART.
Concerning relationships with clinicians, we found
that participants’ perceptions of themselves as living in a
different world from what they called ‘the world that
don’t do drugs’ were important. Such perceptions
followed W.I. Thomas’s (Manis and Meltzer 1967) argu-
ment that when people perceive a situation as “real”, re-
gardless of whether it is objectively authentic, it has real
consequences for them. As experiences that reinforced
their self-perceptions of a lack of credibility in ‘the world
that don’t do drugs’ accumulated, participants could hit
a wall of distrust, in which from a full recovery was sel-
dom perceived as possible (Barbour 1970). Furthermore,
reduced physician trust may "go viral" within communi-
ties with a large number of former prisoners, spreading
to those who have never been to prison themselves
(Schnittker 2015). While trust is a fundamental element
of social capital that underlies both social support and
social participation (Berkman 2000), it was difficult for
some participants to trust clinicians, especially if they
were not included in decision-making about their HIV
treatment. Participants called such clinicians ‘uncaring’
and perceived them as dismissive and patronizing. This
finding builds on recent other studies that show that cli-
nicians play an important role in transitional HIV care
(Hammett et al. 2015b; Sidibe et al. 2015a, b) and em-
phasizes that the onus of trust may not be placed solely
on ex-prisoners who are often expected to reach out to
doctors and activate supportive relationships. Instead,
our study suggests that genuine patient centeredness is a
core element of the medical system’s mandate, and trust
and respect that stems directly from clinicians to ex-
prisoners is a key factor enabling medication adherence.
This echoes research on asymmetrical power relation-
ships (patients versus clinicians) in the medical system,
where ‘acted upon’ patients either reject medicines and
treatments outright or accept them after coercion
(Embuldeniya et al. 2013; Gibson et al. 2012). Further-
more, some patients perceived discrimination at the
hands of their providers for withholding ART from them
solely by virtue of their drug use. This perception is
reciprocally supported by surveys of HIV experts who
would withhold ART if their patient was a PWID
(Westergaard et al. 2012). The literature suggests this
practice is less common among physicians with more
experience treating HIV and working in high drug use
prevalence areas (Westergaard et al. 2012). Drug-using
patients, however, are highly sensitive to poor care and
may interpret physician’s deferring as a sign of
intentional mistreatment (Merrill et al 2002), which
could seriously undermine any nascent trust. In cases
like our participant who liked his doctor and wished to
stop using drugs to ‘please his doctor’ and receive his
medication, such a policy could dissuade patients from
seeking care during relapse, for fear of disappointing
their doctor. It could also reduce medication persistence,
or the the time that the patient remains on therapy (Bae
et al. 2011), due to the patients’ relapse to drug-use, and
the doctors’ suspicion they do so.
Conversely, participants also described genuine
patient-centered care by doctors they perceived as car-
ing, whom they felt sincerely respected them as persons
and included them in making medical decisions. We
found these positive symmetrical relationships when
doctors motivated participants to adhere to ART, and
gave them a sense of hopefulness for the future. This
was described in the earlier literature by the concept of
‘trust in respected others’ (Altice et al. 2001), where in-
stead of reaching down to patients to uplift and improve
them, patients and clinicians are seen more as equal
partners working together towards a common cause in a
mutually supportive and trusting way (Howerton et al.
2007; Wright et al. 2004). We found that even when
family support was not forthcoming, a trusting, mutually
respectful relationship with their physician gave partici-
pants social anchors that inspired them to live and take
ART. This finding extends previous research (Odets
1995) on the HIV epidemic in California in the MSM
community where marginalized gay men had better care
and services once they became diagnosed with HIV.
Such positive relationships with their HIV doctors were
reported by participants to support them over many years,
enduring imminent drug-use relapse, re-incarceration and
other chronic risks.
Importantly here, participants were on average 50 years
and had known about having HIV for nearly 8 years,
which may in part, resulted in them attributing their sur-
vival largely to their own resilience and ability to “man-
age” relationships with individuals and healthcare
systems. Future research, however, might examine how
relationships with family, friends, and clinicians change
over time and how they can differ between those newly
diagnosed and long-term survivors. For example, many
may have seen friends and peers die from complications
of HIV, which could both alter their social networks and
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influence their own medication-taking behaviors in posi-
tive and negative ways. For example, those who had sur-
vived for such a long time might have felt impervious to
HIV, while others may have felt they did not want to
experience the same complications as their peers who
had died.
One important finding here is why, if all partici-
pants had a SUD, some described positive supportive
relationships while others did not. While further
inquiry is required, striking differences in experiences
of positive support versus no support at all among
participants may be grounded in the diversity and
heterogeneity of people and their family histories in
the communities where poverty is concentrated. For
example, why some participants may enjoy more sup-
port than others (while having similar personal char-
acteristics and underlying SUDs) may be shaped by
the history and patterns of their extended family's
geographic and economic mobility, as well as their
extended family engagement with the drug economy
and the criminal justice system (Anderson 1999). Our
participants alluded to these issues when stating their
family or old friends now lived out of state.
Our study also had limitations. First, we only focused
on the accounts of HIV-infected former prisoners but
collected no data from their family, friends, or clinicians.
It would be useful in future research studies to triangu-
late these support structures simultaneously from mul-
tiple perspectives. Since social belonging promoted ART
adherence but social isolation hindered it, it is important
to examine how family, friends, and clinicians reacted to
participants’ efforts towards participation in ‘the world
that don’t do drugs’, and whether this world could let
them in. Second, we interviewed former prisoners once
within 90 days of their release from prison. While serv-
ing time and soon after release, prisoners feel excessive
optimism about changing their health behaviors, but re-
adjust their expectations after encountering difficulties
of transition like finding housing (Harding et al. 2014).
Furthermore, studies elsewhere showed that during and
soon after incarceration former prisoners don’t have a
realistic sense of their likelihood to relapse to drug use,
nursing a false expectation that their addiction is over
(Morozova et al. 2013). There would be merit in inter-
viewing HIV-infected prisoners during incarceration and
several times after release, to dynamically examine their
perspectives regarding social relationships and ART ad-
herence over this period. Third, non-US born former
prisoners who have no family in the United States were
not captured in our sample. This subset of released pris-
oners may experience more social isolation than average,
furthered by language barriers they may face. Fourth, re-
lationships with peers who are healthcare linkage spe-
cialists may also matter to participants’ adherence, but
these were not specifically examined in the interviews,
and whether such peers may be viewed as friends, or as
clinicians. Fifth, for considerations of confidentiality
and to ensure that the participants were comfortable
sharing their experiences through qualitative inter-
views, we did not collect the information about their
incarceration history or the type of their sentence.
While we noted that all participants except one had
been incarcerated more than once, there may be po-
tential differences in the quality of social relationships
between those incarcerated for short periods of time
versus those who were incarcerated for over a year
(Meyer et al. 2013) , as well as between men and
women. These comparisons constitute areas for fur-
ther research. Finally, our participants were enrolled
in a University-based study where a healthcare pro-
vider worked with them over an extended period of
time, linking them to care at HIV clinics or other
clinics where they received ART. Timing facilitated
the building of rapport and bolstered the development
of trusting symmetrical relationships. How these expe-
riences may compare to other HIV-infected ex-
prisoners needs further research.
Conclusions
It would be premature to conclude that support from
their positive symmetrical relationship with doctors, in-
tact families or trustworthy friends could be sufficient
for former prisoners to improve their ART adherence
upon release. Our analyses showed that social relation-
ships between recently released PLH with substance use
disorders, and their families, friends, and clinicians,
occurred in the context of many other unavoidable real-
ities, including persistent unemployment, poverty, the
shortage of safe and affordable housing, economic
insecurity, and social isolation in resource-poor com-
munities to which participants returned after release
(Sledge et al. 2011). The participants invoked the vi-
sion of a vicious cycle where they could not see them-
selves getting healthy unless their other basic needs
for food, clothing, shelter, and employment or other
meaningful social roles could be met. Thus the impact
of social capital on health behaviors must be considered
indispensable in connection to inevitable structural
inequalities (Friedman et al. 2007).
This leads us to making three arguments for practical
implications and improving the status quo. First, our
findings underscore the importance of shared decision-
making between patient and clinician, and clinicians’
ability to form longstanding, trusting and positive rela-
tionship with their HIV patients, which enable ART ad-
herence. Explicitly knowing how much patients value
but also depend on them may empower clinicians as
well as the patients they serve in a positive feedback
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loop. Second, participants’ respect and trust in doctors
suggests that further bundling clinical services with so-
cial services, such as assistance with employment, hous-
ing and social security, may be effective. Mistrust of
some participants towards the medical system stemmed
from their overall experiences of alienation from the
wider society and its institutions (Comfort, 2008). Feel-
ing genuine respect and being taken seriously by a doc-
tor was significant and generated reciprocal trust.
Building on this fledgling mutual trust, collaboration
among all the stakeholders of the process—namely, par-
ticipants, clinicians, employers, welfare officers, and
prison custodial staff—may be a vehicle for positive so-
cial change. Third, while our participants tried staying
away from former friends and environments associated
with drug use to avoid relapse, which echoes research on
Alcoholics and Narcotics Anonymous mutual help orga-
nizations (Polcin et al. 2010), our findings suggest that
discharge planning programs need to support partici-
pants in the community and promote positive social ac-
tivities that will counterbalance negative forces. One
example of such an activity may be participation in clin-
ical studies such as this one (corroborating previous re-
search that HIV-care providers affiliated with academic
institutions facilitate the effective transition of HIV-
infected prisoners to the community through patient-
centeredness and personal connection with the patients)
(Hammett et al. 2015a). Indeed, participants appreciated
that stories of their experiences were heard and valuable,
which enhanced their sense of belonging, trust, and reci-
procity, even if temporarily. Our study affirmed to par-
ticipants they could offer to ‘the world that don’t do
drugs’ a wealth of knowledge and experience, even in-
spired some participants to offer to play the role of the
interviewers in similar studies, and to inquire about
counselors and outreach workers employment positions.
If hired as peer advocates participants like ours can as-
sist newly-released HIV-positive prisoners to navigate
the exigencies of healthcare and social recovery.
The syndemic of HIV, drug use, and incarceration is
exacerbated by the negative and marginalizing factors of
poverty, stigma, and social isolation. Yet we hope that
giving voice to individuals affected by HIV and involving
them throughout the research process helps to bridge
PLH involved in the criminal justice system to the com-
munity and to facilitate a positive transition back into
society.
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